- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06695871
Research on the Application of Patient Navigation-based Management Model of Patients After LEEP
November 16, 2024 updated by: Ren Wenhui, Peking University People's Hospital
Effect of Patient Navigation-based Health Management Model on Quality of Life and Sexual Function After LEEP in Patients With Cervical Lesions
Cervical cancer poses a significant threat to women's health and is a crucial public health issue.
Early detection and treatment of cervical lesions and standardized management have emerged as essential pillars in the Global Cervical Cancer Elimination.
The loop electrosurgical excision procedure (LEEP) is widely employed as a preferred approach for the diagnosis and treatment of precancerous cervical lesions and early invasive cervical cancer.
Patients with high-grade cervical lesions are more prone to experiencing sexual dysfunction and psychological disorders after LEEP, attributed to the unique surgical site, physiological alterations, and psychological stress during the postoperative recovery process, thereby adversely affecting their quality of life.
Currently, there is a shortage of research evidence regarding targeted intervention measures and long-term effect evaluations for sexual function quality and quality of life after LEEP for cervical lesions.
In recent years, the health management model based on patient navigation has evolved into a novel modality for facilitating comprehensive tumor prevention and control.
However, its effect in managing cervical lesions has yet to be comprehensively assessed.
Therefore, we will design a randomized controlled trial to evaluate the impact of a patient navigation-based health management model on quality of life and sexual function after LEEP in patients with cervical lesions.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
128
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Wenhui Ren, PhD
- Phone Number: 86+18800124938
- Email: rwh0617@outlook.com
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100044
- Peking University People's Hospital
-
Contact:
- Wenhui Ren, PhD
- Phone Number: 86+18800124938
- Email: rwh0617@outlook.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Individuals aged between 25 and 50 years;
- LEEP will be conducted following clinical evaluation;
- No intention to conceive within the subsequent year;
- Proficiency in utilizing social media platforms, such as WeChat, is required;
- Patients must be capable of providing informed consent to participate in the study and willing to engage in long-term follow-up.
Exclusion Criteria:
- Individuals who are widowed, separated, or experiencing atypical sexual activity due to reasons related to their spouse.
- Presence of genital tract malformations.
- A history of neurological disorders, such as stroke or epilepsy, or a history of psychiatric conditions, such as depression.
- Patients with other significant illnesses that could impact the long-term follow-up of the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group
The routine clinical outpatient follow-up protocol was implemented, and a postoperative rehabilitation health manual was provided to patients the day following LEEP surgery.
Outpatient evaluations were subsequently conducted at 1 month, 3 months, and 6 months post-surgery.
|
|
|
Experimental: Intervention group
A postoperative rehabilitation health manual was provided to patients the day following LEEP surgery.
The nursing team, possessing over one year of clinical experience in gynecological nursing and psychological counseling, collaborated with clinicians to deliver health consultation services.
They conducted in-person consultations lasting 10-15 minutes during routine outpatient follow-ups at 1, 3, and 6 months post-surgery.
Patients were assessed based on the challenges encountered in postoperative rehabilitation and sexual life, and tailored guidance services were administered.
Additionally, online counseling and guidance services were offered at 2, 4, or 5 months following surgery.
|
A patient navigation-based health management model for individuals with cervical lesions post-LEEP procedure, encompassing healthcare consultation services, personalized health guidance, and routine follow-up assessments.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of Life
Time Frame: six months after LEEP
|
The quality of life six months post-surgery was assessed using 36-Item Short Form Survey.
|
six months after LEEP
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sexual function index
Time Frame: before LEEP, three months after LEEP, and six months after LEEP
|
The Chinese version of the Female Sexual Function Index was used to evaluate the sexual function index at three time points: before LEEP, three months after LEEP, and six months after LEEP.
|
before LEEP, three months after LEEP, and six months after LEEP
|
|
Anxiety
Time Frame: before LEEP, three months after LEEP, and six months after LEEP
|
Anxiety symptoms were assessed using the Self-Rating Anxiety Scale at three-time points: before LEEP, three months after LEEP, and six months after LEEP.
|
before LEEP, three months after LEEP, and six months after LEEP
|
|
Quality of Life
Time Frame: before LEEP and three months after LEEP
|
The quality of life was assessed using 36-Item Short Form Survey.
|
before LEEP and three months after LEEP
|
|
Depression
Time Frame: before LEEP, three months after LEEP, and six months after LEEP
|
Depression symptoms were assessed using the Self-Rating Anxiety Scale at three time points: before LEEP, three months after LEEP, and six months after LEEP.
|
before LEEP, three months after LEEP, and six months after LEEP
|
|
Vaginal discharge
Time Frame: three and six months after LEEP
|
Patient-reported alterations in the volume, color, and odor of vaginal secretions.
|
three and six months after LEEP
|
|
Recurrence rates
Time Frame: three and six months after LEEP
|
The recurrence of cervical lesions at three and six months post-surgery was evaluated using high-risk HPV testing, cytology test, and histopathological examination.
|
three and six months after LEEP
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
December 1, 2024
Primary Completion (Estimated)
December 1, 2025
Study Completion (Estimated)
December 31, 2025
Study Registration Dates
First Submitted
November 16, 2024
First Submitted That Met QC Criteria
November 16, 2024
First Posted (Estimated)
November 19, 2024
Study Record Updates
Last Update Posted (Estimated)
November 19, 2024
Last Update Submitted That Met QC Criteria
November 16, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024PHB398-001
- MBZX0102024007 (Other Grant/Funding Number: Beijing Research Association for Chronic Diseases Control and Health Education)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cervical Intraepithelial Neoplasias
-
Brookdale University Hospital Medical CenterUnknownCarcinoma in Situ of Uterine Cervix | Cervical Intraepithelial Neoplasias | High Grade Cervical Intraepithelial NeoplasiaUnited States
-
Brookdale University Hospital Medical CenterUnknownCervical Cancer | Cervical Intraepithelial Neoplasias | Digital Colposcopy | Precancerous Cervical LesionsUnited States
-
Krankenhaus Barmherzige Schwestern LinzMedical University of ViennaCompletedCervical Intraepithelial Neoplasia Grade 1 | Cervical Intraepithelial Neoplasia Grade 2Austria
-
National Cancer Institute (NCI)CompletedCervical Intraepithelial Neoplasia Grade 2/3 | High Grade Cervical Intraepithelial Neoplasia | Cervical Squamous Cell Carcinoma In Situ | Cervical Squamous Intraepithelial Neoplasia 2United States
-
National Cancer Institute (NCI)TerminatedCervical Cancer | Cervical Intraepithelial Neoplasia Grade 2 | Cervical Intraepithelial Neoplasia Grade 3United States
-
Jonsson Comprehensive Cancer CenterMerck Sharp & Dohme LLCRecruitingCervical Intraepithelial Neoplasia | Cervical Squamous Cell Carcinoma In Situ | Cervical Squamous Intraepithelial Neoplasia 2United States
-
Onconix, IncUnknownCervical Cancer | Cervical Intraepithelial Neoplasia III | Cervical Intraepithelial Neoplasia IIUnited States
-
Nykode Therapeutics ASATheradex; Vaccibody ASCompletedHigh Grade Cervical Intraepithelial NeoplasiaGermany
-
University of Alabama at BirminghamNational Cancer Institute (NCI)CompletedHigh-grade Cervical Intraepithelial NeoplasiaUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedCervical Carcinoma | Cervical Intraepithelial Neoplasia Grade 2/3 | Stage 0 Cervical CancerUnited States
Clinical Trials on Patient navigation-based health management
-
Denver Health and Hospital AuthorityUniversity of Colorado, DenverCompletedObesity | Overweight | ChildrenUnited States
-
Northwestern UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingRetention in Care | Neonatal Morbidity | Maternal Morbidity | Prenatal Care | Antenatal HealthUnited States
-
Renato Cagnacci NetoM.D. Anderson Cancer Center; Eduardo Mondlane University; Hospital Central de... and other collaboratorsCompletedA Prospective Cohort With Patient Navigation as an Intervention for Breast Cancer Patients (NAVIMOZ)Breast Neoplasm Malignant PrimaryMozambique
-
Northwestern UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedContraception | Breastfeeding | Preventive Care / Anticipatory Guidance | Retention in Care | Postpartum HealthUnited States
-
Hugo W. Moser Research Institute at Kennedy Krieger...Recruiting
-
University of FloridaNational Cancer Institute (NCI)Not yet recruitingDiabetes | Obesity & Overweight | Cervical Cancer (Early Detection)United States
-
Northwestern UniversityNortheastern Illinois UniversityCompleted
-
NYU Langone HealthCenters for Disease Control and PreventionRecruitingCancer ScreeningUnited States
-
Matthew Bush, MDNational Institutes of Health (NIH); National Institute on Deafness and Other...RecruitingHearing Loss, Adult-Onset | Hearing Loss, Age-RelatedUnited States
-
University of UtahNational Institutes of Health (NIH); National Center for Advancing Translational... and other collaboratorsCompleted